ABSTRACT
INTRODUCTION
Different strategies are currently used for atrial fibrillation (AF) catheter ablation, but there is a general consensus on pulmonary vein isolation (PVI) with lesions proximal to the ostia [1] . A debate is still ongoing about the amount of left atrium (LA) substrate proximal to the ostia that should be included in the targeting lesion, as antra can be involved in initiation and maintenance of the arrhythmia. The vast majority of AF catheter ablation procedures rely on point-by-point RF applications and they need a double transseptal puncture and additional techniques such as tree-dimensional (3D) mapping systems or intracardiac echocardiography [1] . To simplify the procedure, different technologies and tools have been designed in order to perform a "one-shot" circular lesion at the PVs ostia. One of these tools is an over-the-wire circular decapolar catheter (PVAC, Medtronic, Minneapolis, MN, USA), capable of mapping and ablating using alternating bipolar-unipolar radiofrequency (RF) energy. The feasibility and efficacy of PVAC-based procedures have been already described with results comparable with point-by-point strategies, shorter procedure time and reduced Rx exposure [2] [3] [4] [5] [6] [7] [8] . The aim of this study was to analyse the PVAC lesion setting through a 3D impedance-based electroanatomic mapping (EAM), to assess how proximal the lesion extension is with respect to the PV-LA junction and how it is influenced by anatomical variants.
METHODS

Patients
The study group included patients with symptomatic paroxysmal AF refractory to antiarrhythmic drugs, who underwent bipolar-unipolar RF ablation and EAM, be-tween January and November 2012. Exclusion criteria were the presence of a large left atrium (long axis diameter >50 mm), left appendage thrombus, left ventricular ejection fraction (LVEF) <45%, severe mitral valve disease, severe renal or pulmonary comorbidity, contraindication to oral coagulation and pregnancy.
Electrophysiological Study and 3D Voltage Mapping
All patients received oral anticoagulation therapy for at least 4 weeks up to 3 days before the procedure, then replaced by a low molecular weight heparin. A computed tomography (CT) scan of the heart and a transoesophageal echocardiogram were performed within 48 hours before the procedure. Surface and bipolar electrocardiograms (ECGs) were continuously monitored and recorded. LA access was gained through a single transseptal puncture to position a steerable 9.5 F sheath (Channel, Bard EP, Lowell, MA, USA), continuously perfused with 0.9% saline solution. After the transseptal puncture, intravenous heparin was administered as a bolus (100 IU/kg) followed by infusion, to achieve and maintain a target activated clotting time of 350 s. A 3D reconstruction of the LA and PVs was performed using the NavX system (EnSite NavX, St Jude Medical, St Paul, MN, USA). A circular multipolar mapping catheter (Inquiry A-Focus II, St Jude Medical) was used for the acquisition of the 3D geometry, which was then compared side by side to the CT scan-derived anatomy. PVs ostia were tagged at the intersection of the tangential lines to PVs and LA walls [9] . A common PV was defined as a unique take-off of contiguous PVs, bifurcating > 5 mm distal to the PV-LA junction. The proximal border of the antra has not been standardized yet, but arbitrarily we judged the antral extension for lesions occurring > 5 mm from the PVs ostia. PVs ostia were anatomically characterized by measurement of the maximum and minimum diameter and the relative ratio, defining round shaped ostia for a value ≤ 1.2 and oval shaped ostia for a ratio > 1.2 [10] . Bipolar voltage maps were acquired before and after PVs isolation in sinus rhythm. The following settings were used: interpolation of 10 mm, internal and external projections of 5 mm. Normal ECGs were evaluated for voltage recordings greater than 0.5 mV and were displayed in purple. Voltage abatement was considered for potentials ranging from 0.5 to 0.05 mV displayed in a spectrum of colours ranging from red to blue, and for signals lower than 0.05 mV marked in grey and conventionally considered as electrically silent [11] . Off-line quantitative voltage analysis was performed collecting voltage values of points mapped at each PV-LA junction and relative proximal segment of the vein, listed as below: LSPV for the left superior PV, LIPV for the left inferior PV, LCPV for the left common PV, RSPV for the right superior PV and RIPV for the right inferior PV.
Multipolar Radiofrequency Catheter Ablation
Ablation of PVs was performed using the PVAC, a decapolar circular over-the-wire catheter capable of mapping and ablation. The distal circular loop, measuring 25 mm in diameter, can be steered in a bidirectional fashion and extended in a spiral configuration. The ablation requires a specifically designed RF generator (GENius, Ablation Frontiers, Medtronic, USA), that allows RF delivery in various settings of bipolar/unipolar energy output and, through continuous temperature monitoring in each electrode, restrict the power output to a maximum of 10 watts. The location of the decapolar ring was checked both using fluoroscopy and the 3D PVs-LA reconstruction. RF energy was delivered for 60 s with a temperature limit of 60˚C, with a bipolar/uniratio of 2:1 when the catheter was in close proximity to the PV antrum and 4:1 if the position was more ostial. Cavotricuspid isthmus ablation was also performed using an 8-mm tip RF ablation catheter if a typical right atrial flutter was observed during the procedure or previously documented.
Confirmation of Pulmonary Vein Isolation
Before NavX remapping, PVI was always checked using the PVAC and then a standard circular multipolar catheter (Inquiry A-Focus II, St Jude Medical). Electrical deconnection was assessed by abatement of local potentials in sinus rhythm and during atrial pacing and by achievement of PVs-LA conduction block. Entry conduction block was demonstrated by the absence or dissociation of PVs potentials. Exit block was assessed by pacing at high output (10 V at 2 ms) from all electrode pairs of the catheter, positioned in the proximal PVs and at the ostia. Persistence of PVs isolation was assessed again in all the PVs at the end of the study. No pharmacological tests were performed.
Statistical Analysis
Statistical analysis was performed using SPSS 12.0 for Windows (SPSS, Inc., Chicago, IL, USA) Continuous data are expressed as mean values ± standard deviation. Categorical variables are expressed as a percentage. Differences between distributions were compared with a paired t-test for paired data and unpaired t-test for independent values. Differences in proportions were compared with a Fisher's exact test. A P value < 0.05 was considered statistically significant.
RESULTS
Patient Characteristics
PVAC lesion setting was evaluated in twenty patients who underwent alternating bipolar/unipolar RF ablation and impedance-based EAM. Mean age of the patients was 59 ± 10 years, 14 were males and 6 females. All the patients suffered from drug-refractory paroxysmal atrial fibrillation with a mean CHADS2 Score of 1.2 ± 0.4. Echocardiographic recordings demonstrated a mean LA diameter of 41 ± 5 mm and a mean LVEF of 55% ± 6%. PVs anatomy, ostial size, and shape are summarized in Table 1 . Seventeen patients had 4 veins each (LSPV, LIPV, RSPV and RIPV) and three patients had three veins (left common PV, RSPV and RIPV). The PV ostial shape was classified as oval in 41/77 (53%) and round in 36/77 (47%) veins. Oval ostia had a greater incidence in left than in right PVs: 24/37 (65%) vs 17/40 (43%), p = ns. Round ostia were more frequently in right than in left PVs: 23/40 (57%) vs 13/37 (35%), p = ns.
Multipolar Radiofrequency Catheter Ablation
PVAC was able to target and isolate all the 77 PVs, including the three LCPVs, independently from size and shape of the PV ostium. The mean number of duty-cycled RF applications per patient was 26 ± 9 (range 19 -44) with a mean energy delivery time of 24 ± 6 (range 19 -40) min. The fluoroscopy time was 51 ± 14 min, including both the time for PVAC mapping and ablation and the time due to catheter manipulation for voltage mapping. Five patients also underwent cavotricuspid isthmus ablation.
3D Voltage Mapping
The voltage maps were collected before and after PVI through the acquisition of 343 ± 63 and 371 ± 85 points, respectively (p = ns). Before ablation all the points mapped at the PVs antra and in the proximal tubular portion of the veins had a normal voltage (Figures 1(a) and  (b) ). After ablation a voltage reduction was evident in all the PVs and to different extent proximal to their ostia (Figures 1(c) and (d) Antral extension of RF lesions were evident in the whole antra in 9/38 veins and limited to a part of the PV antrum in 29/38 (76%) PVs: the posterior wall in 24 and the anterior wall in 5 PV antra.
DISCUSSION
Our data confirm the results of a previous study [12] about the ability of PVAC to perform PVI at the proximal ostium, even in more challenging anatomical variants as three left common PVs, in which ostial lesions were carried out by insertion of the guide in different venous branches.
After RF ablation, the impedance-based EAM showed a significant reduction in the bipolar voltage at the PV ostia, proximal to the tubular part of the PVs. However about one in four veins, frequently the larger ones, showed a segment of reduced voltage abatement at the anatomic PV ostium with slightly distal low voltage encircling. Far-field signal recording, particularly frequent in left-sided veins because of their proximity to the left atrial appendage, was ruled out by remapping with standard catheters and pacing maneuvers. On the other hand, a partial sided placement of the PVAC at the ostia may be the cause of the distal segmental voltage abatement: before RF erogation in any new catheter position, the location of the PVAC was displayed on the 3D mapping system, but a tiny displacement may have occurred as a consequence of the pressure exerted during RF delivery in order to achieve a better contact and the target temperature.
In our experience antral extension of RF lesions was achieved more frequently in round veins, as counterclockwise catheter rotation allows a wider sweep more easily around the circumference of round PV ostia. More often the antra were partially affected by RF lesions, probably as a result of different causes. Firstly, the PV's short axis is oriented approximately in the anteroposterior direction. Secondly, the transseptal access naturally directs the catheter posteriorly into the LA, so that its circular ending is obliquely oriented with the anterior part located at the PV ostia and the posterior part more atrial. Finally, a greater antral contact was more easily achieved posteriorly by bending and rotating the catheter around the ostial circumference. On the contrary, the small distance between the left PVs and the LA appendage [10] can limit the placement of the circular catheter in the anterior LA walls more than that of a single-tip catheter.
In our study the fluoroscopic and procedural mean times were longer than those previously described [2] [3] [4] [5] [6] [7] [8] , because the procedure required an additional EAM and probably a different learning curve, since the mean number of RF applications was similar.
The PVAC is an over-the-wire catheter designed to be managed under fluoroscopic control, with more detailed definition of the PV-LA junction usually achieved by angiography. A small risk of PV stenosis is described in some studies [13, 14] . In our experience the 3D-geometry reconstruction eased the positioning of the PVAC at the ostia and the parallel orientation to the PV's walls, but was not useful for catheter navigation as it is conditioned by the over-the-wire design. Regarding the voltage maping, the low voltage signals recorded are not accurate enough to indicate PVI, which in fact was validated with electrophysiological entry and exit blocks. Moreover, maps can be affected by far-field potentials, particularly from the left atrial appendage, thus requiring accurate characteristics analysis and pacing maneuvers. As the PVAC-EAM combined strategy is more expensive and 
OPEN ACCESS
This study outlines the significance of two factors in order to choose the more effective ablation tool: the knowledge of the individual anatomy that is useful to perform a right positioning of the circular mapping-ablation catheter, and the a priori preference of a wide encircling PVI strategy that is easier to achieve with a single-point RF catheter.
Limitations
This study analyzed the primary lesion setting after PVAC ablation in a relatively small but representative group of patients, referred for paroxysmal AF catheter ablation.
PVI was assessed by standard electrophysiological criteria as there is no absolute agreement between myocardial viability and low voltages and also because the maps can be affected by LA far-field potentials. As repeated mapping procedures were not performed, the study does not clarify to what extent the ablation lesions remain permanent.
CONCLUSION
Electrical PVI with PVAC is not affected by the size and shape of the PV ostium and results in low voltage areas mainly at the PV ostium and proximal LA. However, voltage reduction in the whole circumference of the anatomic PV ostia is more challenging in larger veins, and antral lesions are variable in occurrence and extension, so knowledge of the individual anatomy of the PVs and LA can be useful in order to choose the more effective ablation tool.
